Follow-Up Study on Children Exposed to Trauma
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Post-traumatic Stress Disorder (PTSD), Complex Post-Traumatic Stress Disorder (CPTSD). Basic parameters: 7 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Trauma-Exposed Children and Adolescents: A One-Year Follow-Up Study
Overview
As far as it is known, there is no longitudinal study in Turkey investigating the follow-up and treatment of children and adolescents exposed to trauma. This study is planned to reassess children and adolescents with trauma exposure who were evaluated in Istanbul Faculty of Medicine Child Psychiatry outpatient clinic as part of a thesis study one year ago (January-April 2024) and to examine how many of them continue to meet the criteria for Post-Traumatic Stress Disorder (PTSD), how many receive a diagnosis of Complex Post-Traumatic Stress Disorder (CPTSD), and which factors are associated with these outcomes. In this way, it is aimed to contribute to the literature on the long-term effects of trauma exposure. Additionally, since there is no scale in our country that assesses the diagnosis of CPTSD in children, the study also aims to translate the Child and Adolescent Trauma Screen Scale - 2 (CATS-2) into Turkish and examine its psychometric properties.
Detailed description
This study will be conducted under the coordination of Istanbul Faculty of Medicine, Department of Child and Adolescent Psychiatry. Children and adolescents between the ages of 7-18 who have been exposed to trauma and who applied to the Child and Adolescent Psychiatry outpatient clinic of Istanbul Faculty of Medicine and who were evaluated within the scope of the thesis study one year ago (January-April 2024) will be re-evaluated one year later. It is aimed to reach all 210 children and adolescents and evaluate those who agree to participate in the study.
Sample:
* Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study one year ago (January-April 2024), * Children and adolescents aged 7-18, * Children and/or parents with adequate literacy and Turkish language skills, * Those without psychotic/manic symptoms or a diagnosis of autism spectrum disorder or intellectual disability in the child or parent during the interview, * Volunteers who agree to participate in the study.
Researchers will explain the study to volunteer children and their families and present the Informed Consent Form to determine their willingness to participate.
Parents of eligible volunteers will complete the following assessments:
* Sociodemographic Data Form * Hospital Anxiety and Depression Scale * Advers Childhood Events Scale * Positive Childhood Experiences Scale * Strengths and Difficulties Questionnaire (Parent Form) * Child and Adolescent Trauma Screen 2 - Caregiver Report
Volunteer children and adolescents will complete:
* Child and Adolescent Trauma Screen 2 - Self Report * Revised Children's Anxiety and Depression Scale * Positive Childhood Experiences Scale * (Adolescent/Child's Self Report) Responses to Stress Questionnaire (Peer Stress)
The clinician will conduct the following assessments:
* ICD-11-based clinical interview * UCLA PTSD Reaction Index for DSM-5 * Children's Global Assessment Scale (CGAS)
The start date for the study is February 17, 2025, and data analysis will commence afterward. Data will be analyzed using the Statistical Program for Social Sciences (SPSS for Windows, version 21.0). The study is expected to be completed by July 2025.
The coordinating center responsible for the research is the Department of Child and Adolescent Psychiatry at Istanbul Faculty of Medicine.
Primary outcome measures
- Prevalence of PTSD and Complex PTSD in Children and Adolescents Exposed to Trauma [Time frame: Baseline]
- Factors Associated with the Diagnosis of PTSD and Complex PTSD [Time frame: Baseline]
- Adaptation of the Child and Adolescent Trauma Screen - 2 into Turkish, Evaluation of Its Psychometric Properties [Time frame: Baseline]
Eligibility criteria
Inclusion criteria
- Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study one year ago (January-April 2024),
- Children and adolescents aged 7-18,
- Children and/or parents with adequate literacy and Turkish language skills.
Exclusion criteria
- The presence of psychotic/manic symptoms in the child or parent during the interview or any condition that makes the interview and assessment impossible (e.g., mental or developmental condition or a different communication language),
- The child or parent refusing to participate in the study,
- The presence of autism spectrum disorder or intellectual disability at a severity that prevents assessment.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Family-based
Study locations
Turkey (Türkiye) · 1 center
- Istanbul Faculty of Medicine — Istanbul
Publications
- Kucukardali RS, Karal BN, Ozkal A, Erus SM, Gormez V, Orengul AC. Validation of the Child and Adolescent Trauma Screen-2 (CATS-2) in a Turkish clinical sample: psychometric properties across ICD-11 and DSM-5 frameworks. Eur J Psychotraumatol. 2026 Dec;17(1):2694190. doi: 10.1080/20008066.2026.2694190. Epub 2026 Jul 28. PMID 42517355
Identifiers
NCT: NCT06975852 · 2025/156